Critical

Targeted temperature management (post-arrest)

TTM · Critical Care / ICU
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Controlled temperature after cardiac arrest for neuroprotection. Book era: induced hypothermia 32–34°C after VF arrest (HACA/Bernard 2002). 2020s practice: actively PREVENT FEVER (target ≤37.5–37.7°C) for ≥72 h; routine cooling to 33°C showed no outcome benefit vs 36°C (TTM 2013) or vs fever-avoidance (TTM2 2021).

Red flags

  • Fever in the first 72 h post-arrest worsens outcome — treat aggressively
  • Rewarming (if cooled) no faster than 0.25–0.5°C/h

Management

  • Comatose after ROSC: sedate, ventilate to normoxia/normocapnia, MAP ≥65–70
  • Continuous core temperature; use surface/intravascular devices to hold the target and PREVENT fever ≥37.8°C for at least 72 h
  • Treat shivering: magnesium, counter-warming of hands/face, sedation, ± paralysis
  • Watch during any cooling: bradycardia, hypokalaemia→rebound hyperkalaemia, hyperglycaemia, coagulopathy, infection risk
  • Prognosticate no earlier than 72 h normothermic, multimodal (exam, NSE, EEG, SSEP, imaging)

The modern target is “no fever, tightly controlled” — device-driven temperature control with proper sedation.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.